HHS Genetic Testing Advisory Committee To Include Device, CLIA Panel Reps
This article was originally published in The Gray Sheet
HHS' planned Advisory Committee on Genetic Testing will include at least one active member of FDA's Medical Devices Advisory Committee and the Clinical Laboratory Improvement Advisory Committee, according to the group's charter.
You may also be interested in...
HHS' Advisory Committee on Genetic Testing will solicit public input at a Jan. 27 meeting to help determine an appropriate mechanism for the collection and analysis of data on the analytical validity, clinical validity and clinical utility of genetics tests, panel members agreed at their Oct. 26 meeting.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.